XOMA Royalty Corp

Pharmaceutical Preparations · EMERYVILLE · CA

Distress signal

Moderate confidence (50%)

Updated Oct 14, 2026, 12:02 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: XOMA Royalty Corp deregistered its securities (Jul 27, 2026)

Timeline

Every material event, newest first. History is never overwritten.

XOMA Royalty Corp deregistered its securities
Jul 27, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 d368035d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39801 XOMA ROYALTY LLC (Exact name of registrant as specified in its charter) 2200 Powell Street, Suite 310 Emeryville, California 94608 (510) 204-7200 (Address, including zip code, and telephone number, including area code, of reg…”
XOMA Royalty Corp was delisted from its exchange
Jul 16, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0000791908 XOMA Royalty Corp 001-39801 2200 Powell St, Suite 310 Emeryville CA CALIFORNIA 94608 510-204-7239 Dep Shs Rep Series B 8.375% Cumulative Pfd Stk & 8.625% Ser A Cumulative Perpetual Pfd Stk 17 CFR 240.12d2-2(a)(1) Jennifer Fainer CDO Analyst 2026-07-16”
XOMA Royalty Corp was delisted from its exchange
Jul 14, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0000791908 XOMA Royalty Corp 000-39801 2200 Powell St, Suite 310 Emeryville CA CALIFORNIA 94608 510-204-7239 Common Stock 17 CFR 240.12d2-2(a)(3) Jennifer Fainer CDO Analyst 2026-07-14”
XOMA Royalty Corp received a delisting notice from its exchange
Jul 13, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information contained in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. In connection with the Closing of the Merger, the Company (i) notified The Nasdaq Global Market ( Nasdaq ) that the Merger was consummated and (ii) requested that Nasdaq (A) halt trading of and delist the Shares effective before the opening of trading on July 14, 2026, and (B) file with the SEC a Form 25 Notification of Removal from List…”

Sources

Every material source used to build this profile.

SEC Company Submissions (TIER 1 · UNVERIFIED)
XOMA Royalty Corp — Pharmaceutical Preparations (SIC 2834) — EMERYVILLE, CA
View source record
SEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 d368035d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39801 XOMA ROYALTY LLC (Exact name of registrant as specified in its charter) 2200 Powell Street, Suite 310 Emeryville, California 94608 (510) 204-7200 (Address, including zip code, and telephone number, including area code, of reg…
View source record
SEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0000791908 XOMA Royalty Corp 001-39801 2200 Powell St, Suite 310 Emeryville CA CALIFORNIA 94608 510-204-7239 Dep Shs Rep Series B 8.375% Cumulative Pfd Stk & 8.625% Ser A Cumulative Perpetual Pfd Stk 17 CFR 240.12d2-2(a)(1) Jennifer Fainer CDO Analyst 2026-07-16
View source record
SEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0000791908 XOMA Royalty Corp 000-39801 2200 Powell St, Suite 310 Emeryville CA CALIFORNIA 94608 510-204-7239 Common Stock 17 CFR 240.12d2-2(a)(3) Jennifer Fainer CDO Analyst 2026-07-14
View source record
SEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information contained in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. In connection with the Closing of the Merger, the Company (i) notified The Nasdaq Global Market ( Nasdaq ) that the Merger was consummated and (ii) requested that Nasdaq (A) halt trading of and delist the Shares effective before the opening of trading on July 14, 2026, and (B) file with the SEC a Form 25 Notification of Removal from List…
View source record

Status history

Every derived status, with the rule that produced it.

DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:15 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:03 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:21 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

What is happening

Timeline

Company information

Sources

Status history